“In some cases, that meant that we could actually go after the primary pathology or the primary cause of the condition in a way that we never would have thought of before." Cerebral palsy (CP) has ...

Welcome to this Contemporary Pediatrics poll. Take a look at the following case below. After reading through the description, choose a multiple choice answer and try to guess the correct patient ...

Study findings underscore the effectiveness of a dual approach to RSV prevention. The RSVpreF vaccine induces passive immunity by transferring protective antibodies to the fetus, while nirsevimab, a ...

Panelists discuss the prevalence of treatment-refractory moderate to severe atopic dermatitis, noting factors such as intolerance or inability to use high-potency topical agents as common reasons for ...

0.05% atropine was associated with a higher incidence of mild side effects, though it was more effective in controlling myopia progression compared to 0.01% atropine or placebo. A new study published ...

Panelists discuss treatment expectations for newer systemic agents, highlighting data on efficacy onset and persistence, including rapid improvement in pruritus with dupilumab by week 2 (SOLO trials), ...

A study found that teens with obesity eat more later in the day than their peers, highlighting the role of the body’s circadian system in eating habits. A new study from researchers at Mass General ...

Amin Barakat, MD, FAAP, details meningococcal disease vaccines and highlights the recently FDA-approved MenABCWY vaccine from GSK. Invasive meningococcal disease (IMD) is a life-threatening infection ...

90-day interim biopsy data in the first 3 patients revealed an average microdystrophin expression of 110% and improvements in muscle health and resilience biomarkers. Positive initial data has been ...

Nurse practitioner Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN offers her thoughts on the recent FDA approval of GSK's meningococcal ABCWY vaccine. On February 14, 2025, the FDA approved ...

Sanjiv Harpavat, MD, PhD, FAAP, lead author of a clinical report recently released by the AAP on identifying infants with biliary atresia, joined to discuss the report and guidance for primary care. A ...

The FDA has accepted PTC Therapeutics' NDA for vatiquinone, a potential treatment for Friedreich's ataxia, with a decision expected by August 19, 2025. PTC Therapeutics has announced that the FDA has ...